Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Roles for miRNAs in endocrine resistance in breast cancer
Penn Muluhngwi, Carolyn M. Klinge
Endocrine Related Cancer (2015) Vol. 22, Iss. 5, pp. R279-R300
Open Access | Times Cited: 78

Showing 26-50 of 78 citing articles:

Predictive and Prognostic Value of Selected MicroRNAs in Luminal Breast Cancer
Isabel Amorim, João Lobo, Mário Fontes-Sousa, et al.
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 37
Tamoxifen differentially regulates miR-29b-1 and miR-29a expression depending on endocrine-sensitivity in breast cancer cells
Penn Muluhngwi, Abirami Krishna, Stephany L. Vittitow, et al.
Cancer Letters (2016) Vol. 388, pp. 230-238
Open Access | Times Cited: 36
The upregulation of miRNA-146a inhibited biological behaviors of ESCC through inhibition of IRS2
Haibo Liu, Guohua Ren, Liangming Zhu, et al.
Tumor Biology (2015) Vol. 37, Iss. 4, pp. 4641-4647
Closed Access | Times Cited: 35
Differential microRNA profiles between fulvestrant-resistant and tamoxifen-resistant human breast cancer cells
Qian Zhou, Hui Zeng, Peng Ye, et al.
Anti-Cancer Drugs (2018) Vol. 29, Iss. 6, pp. 539-548
Closed Access | Times Cited: 35
The miR-29 transcriptome in endocrine-sensitive and resistant breast cancer cells
Penn Muluhngwi, Negin Alizadeh‐Rad, Stephany L. Vittitow, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 34
Dual-target inhibitors based on ERα: Novel therapeutic approaches for endocrine resistant breast cancer
Shuangshuang Xiong, Ke Song, Hua Xiang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 270, pp. 116393-116393
Closed Access | Times Cited: 3
The lncRNA n340790 accelerates carcinogenesis of thyroid cancer by regulating miR-1254.
Qinghuai Li, Wei Shen, Xiaoyu Li, et al.
PubMed (2017) Vol. 9, Iss. 5, pp. 2181-2194
Closed Access | Times Cited: 30
Inflamma-miRs in Aging and Breast Cancer: Are They Reliable Players?
Cristina-Sorina Cătană, George A. Călin, Ioana Berindan‐Neagoe
Frontiers in Medicine (2015) Vol. 2
Open Access | Times Cited: 29
Bioinformatics-based identification of miR-542-5p as a predictive biomarker in breast cancer therapy
Qiong-Ni Zhu, Helen J. Renaud, Ying Guo
Hereditas (2018) Vol. 155, Iss. 1
Open Access | Times Cited: 29
Effect of a high-intensity interval training on serum microRNA levels in women with breast cancer undergoing hormone therapy. A single-blind randomized trial
Shaban Alizadeh, Amin Isanejad, Sanambar Sadighi, et al.
Annals of Physical and Rehabilitation Medicine (2019) Vol. 62, Iss. 5, pp. 329-335
Open Access | Times Cited: 26
microRNA-221 and tamoxifen resistance in luminal-subtype breast cancer patients: A case-control study
Alfiah Amiruddin, Muhammad Nasrum Massi, Andi Asadul Islam, et al.
Annals of Medicine and Surgery (2021) Vol. 73
Open Access | Times Cited: 23
MicroRNAs as Potential Predictors of Response to CDK4/6 Inhibitor Treatment
Αngeliki Andrikopoulou, Almog Shalit, Eleni Zografos, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4114-4114
Open Access | Times Cited: 21
Identification and Roles of miR-29b-1-3p and miR29a-3p-Regulated and Non-Regulated lncRNAs in Endocrine-Sensitive and Resistant Breast Cancer Cells
Penn Muluhngwi, Carolyn M. Klinge
Cancers (2021) Vol. 13, Iss. 14, pp. 3530-3530
Open Access | Times Cited: 20
Non coding RNA analysis in fibrolamellar hepatocellular carcinoma
Benjamin A. Farber, Gadi Lalazar, Elana P. Simon, et al.
Oncotarget (2017) Vol. 9, Iss. 12, pp. 10211-10227
Open Access | Times Cited: 26
Mechanisms of resistance to selective estrogen receptor down-regulator in metastatic breast cancer
Doudou Huang, Fang Yang, Yucai Wang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2017) Vol. 1868, Iss. 1, pp. 148-156
Closed Access | Times Cited: 25
High N-Acetyltransferase 1 Expression is Associated with Estrogen Receptor Expression in Breast Tumors, but is not Under Direct Regulation by Estradiol, 5α-androstane-3β, 17β-Diol, or Dihydrotestosterone in Breast Cancer Cells
Xiaoyan Zhang, Samantha M. Carlisle, Mark A. Doll, et al.
Journal of Pharmacology and Experimental Therapeutics (2018) Vol. 365, Iss. 1, pp. 84-93
Open Access | Times Cited: 25
microRNAs in the haemostatic system: More than witnesses of thromboembolic diseases?
Ana B. Arroyo, Ascensión M. de los Reyes‐García, Raúl Teruel‐Montoya, et al.
Thrombosis Research (2018) Vol. 166, pp. 1-9
Closed Access | Times Cited: 25
Non-coding RNAs as Mediators of Tamoxifen Resistance in Breast Cancers
Mohd Farhan, Mohammad Aatif, Prasad Dandawate, et al.
Advances in experimental medicine and biology (2019), pp. 229-241
Closed Access | Times Cited: 23
Advances of Exosomal miRNAs in Breast Cancer Progression and Diagnosis
Wenwen Chen, Zhongyu Li, Pengwei Deng, et al.
Diagnostics (2021) Vol. 11, Iss. 11, pp. 2151-2151
Open Access | Times Cited: 18
Novel Endocrine Therapeutic Opportunities for Estrogen Receptor-Positive Ovarian Cancer—What Can We Learn from Breast Cancer?
Tine Ottenbourgs, Els Van Nieuwenhuysen
Cancers (2024) Vol. 16, Iss. 10, pp. 1862-1862
Open Access | Times Cited: 2
Oestrogen receptor negativity in breast cancer: a cause or consequence?
Vijaya Narasihma Reddy Gajulapalli, Vijaya Lakshmi Malisetty, Suresh Kumar Chitta, et al.
Bioscience Reports (2016) Vol. 36, Iss. 6
Open Access | Times Cited: 22
MiR-4653-3p and its target gene FRS2 are prognostic biomarkers for hormone receptor positive breast cancer patients receiving tamoxifen as adjuvant endocrine therapy
Xiaorong Zhong, Guiqin Xie, Zhang Zhang, et al.
Oncotarget (2016) Vol. 7, Iss. 38, pp. 61166-61182
Open Access | Times Cited: 20
Regulatory Interplay between miR-181a-5p and Estrogen Receptor Signaling Cascade in Breast Cancer
Rosaria Benedetti, Chiara Papulino, Giulia Sgueglia, et al.
Cancers (2021) Vol. 13, Iss. 3, pp. 543-543
Open Access | Times Cited: 16
MicroRNA regulation of the serine synthesis pathway in endocrine-resistant breast cancer cells
Belinda J. Petri, Kellianne M. Piell, Ali E. Wilt, et al.
Endocrine Related Cancer (2023) Vol. 30, Iss. 11
Closed Access | Times Cited: 6
The overexpression of miR-30a affects cell proliferation of chondrosarcoma via targeting Runx2
Dong Jiang, Xiaoming Zheng, Wei Shan, et al.
Tumor Biology (2015) Vol. 37, Iss. 5, pp. 5933-5940
Closed Access | Times Cited: 20

Scroll to top